[Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].
作者信息
Gziut Aneta I, Pastwa Łukasz, Słysz Andrzej
机构信息
Klinika Kardiologii Inwazyjnej CSK MSWiA, ul. Wołoska 137, 02-507 Warszawa.
出版信息
Kardiol Pol. 2006 Mar;64(3):334-6; discussion 337-8.
PMID:16583343
Abstract
摘要
相似文献
1
[Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].
Kardiol Pol. 2006 Mar;64(3):334-6; discussion 337-8.
2
Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
Catheter Cardiovasc Interv. 2004 Aug;62(4):445-52. doi: 10.1002/ccd.20101.
3
Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial.
Am J Cardiol. 1999 Sep 15;84(6):728-30, A8. doi: 10.1016/s0002-9149(99)00421-x.
4
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
Circulation. 2009 Apr 14;119(14):1933-40. doi: 10.1161/CIRCULATIONAHA.108.818617. Epub 2009 Mar 30.
5
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Circulation. 2003 Sep 16;108(11):1316-23. doi: 10.1161/01.CIR.0000087601.45803.86. Epub 2003 Aug 25.
6
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials.
Platelets. 2012;23(4):274-81. doi: 10.3109/09537104.2011.619602. Epub 2011 Oct 11.
7
Bleeding complications of platelet glycoprotein IIb/IIIa inhibitor abciximab (ReoPro ).
J Invasive Cardiol. 2002 Jul;14(7):423-5.
8
Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
Am Heart J. 2004 May;147(5):865-73. doi: 10.1016/j.ahj.2003.11.009.
9
Care of the patient receiving ReoPro following angioplasty.
J Invasive Cardiol. 1994;6 Suppl A:38A-42A; discussion 54A-56A.
10
Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.
Mayo Clin Proc. 2001 Sep;76(9):890-6. doi: 10.4065/76.9.890.
Zotero 插件